Body and Mind Inc. BAMM BMMJ said on Wednesday that its wholly owned subsidiary, DEP Nevada, Inc., has closed the previously announced transaction to sell all of its interests in the Body and Mind Ohio dispensary for $8.225 million in cash.
What Happened
DEP Nevada entered into an equity purchase agreement with FarmaceuticalRX, LLC in July, whereby DEP agreed to sell all of the issued and outstanding interests, equity or profit interests in NMG OH 1, LLC, which owns and operates the Body and Mind Ohio dispensary, to the purchaser.
The deal includes an additional $2.5 million in potential contingent proceeds.
Simultaneously with the closing of the disposition of the dispensary, the company has fully repaid its $7.33 million debt owing to its senior secured lender.
Why It Matters
The Las Vegas company plans to use the proceeds from the disposition of the dispensary to fund the development of its retail assets in Illinois and New Jersey.
"The closing of the Ohio dispensary divestment and early repayment of our senior secured debt allows us to continue to develop our prime retail assets in Illinois and New Jersey, substantially lowers our interest expenses by roughly US$1 million per year and provides the potential for BaM to benefit from future Ohio adult use legalization," Body and Mind CEO Michael Mills said.
The Body and Mind Ohio dispensary opened in 2019.
What's Next
Mills explained in a press release what's next for the company.
"We remain hyper-focused on building a strong operations-centric portfolio of cannabis dispensaries," he said. "Our dispensary in Markam, Illinois, will be hosting a customer appreciation day on October 20th with an opportunity for customers to connect with many local and national brands."
Mills also provided an update on constructing the new dispensaries in Illinois and New Jersey.
"Dispensary construction in Lynnwood, Illinois, is progressing with all walls complete, roof trusses installed and earthworks ongoing," he said. "The dispensary license in Lawrenceville, New Jersey, continues to be in the permitting process for its annual license and approval of the building permit. We look forward to providing updates on our continued progress in the future."
BMJ Price Action
Body and Mind's shares traded 23.5968% lower at $0.0667 per share at the time of writing on Wednesday morning.
Related News
- Body And Mind Q3 FY23 Revenue Declines 7% YoY, What About Adjusted EBITDA?
- Body And Mind Enters Illinois Cannabis Market
- Body And Mind Q2 FY23 Revenue Declines 3.75% YoY, What About Adjusted EBITDA?
Did you miss the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth. Join Benzinga PotProfits. Benefit from Michael Berger’s sharp analysis, revealing top cannabis stock opportunities and timely updates. Experience the potential of 10%+ returns in just 90 days. Our 4.5-star Marketfy rating speaks volumes. Secure your position in this booming sector with a 30-day money-back guarantee. The time to invest is now before everyone else realizes it. Secure your profits with Benzinga. Click here now to learn more.
Photo: Courtesy of Geralt and Kindel Media by Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.